Evidence Gaps and Global Patterns in Leishmaniasis Control: A Scoping Review of Clinical, Diagnostic, and Treatment Strategies. [PDF]
Mohammed MW +4 more
europepmc +1 more source
Development of a 17-DMAG-Loaded Carboxymethylcellulose Gel for <i>In Vivo</i> Treatment of Cutaneous Leishmaniasis. [PDF]
Cruz KP +16 more
europepmc +1 more source
Synthesis and Antileishmanial Activity of Cinnamic Acid-Amantadine Amides. [PDF]
Fernandes ÉB +17 more
europepmc +1 more source
Revisiting Leishmania (Viannia) lainsoni Silveira, Shaw, Braga, and Ishikawa, 1987: current knowledge and emerging perspectives. [PDF]
de Morais TG +3 more
europepmc +1 more source
Response and therapeutic failure to meglumine antimoniate, the first-line drug for cutaneous leishmaniasis infections in Colombian soldiers. [PDF]
Pavia PX +6 more
europepmc +1 more source
Zoonotic trypanosomatids in small mammals at a wildlife-urban interface in southeastern Brazil: Implications for transmission risk. [PDF]
Madureira ACC +15 more
europepmc +1 more source
Lipid Mediators in Host-Pathogen Interactions during <i>Leishmania</i> Infection: Friends or Foes? [PDF]
Andrade YMFS +7 more
europepmc +1 more source
LAMP-coupled CRISPR-Cas12a assays: A promising new tool for molecular diagnosis of leishmaniasis. [PDF]
Dueñas E +9 more
europepmc +1 more source
<i>Crithidia fasciculata</i> Shows Non-Pathogenic Behavior in Leishmania Co-Infection Related to Temperature Stress, In Vitro and In Vivo Infections, and Amphotericin B Susceptibility. [PDF]
Santos JFBD +10 more
europepmc +1 more source
Immunopeptidomics of cutaneous leishmaniasis patients reveals the natural antigenic landscape. [PDF]
de Vrij N +24 more
europepmc +1 more source

